Post-translational modifications of naturally processed MHC-binding epitopes.
about
DRiPs solidify: progress in understanding endogenous MHC class I antigen processingPhosphorylation-dependent interaction between antigenic peptides and MHC class I: a molecular basis for the presentation of transformed selfStructural basis for the presentation of tumor-associated MHC class II-restricted phosphopeptides to CD4+ T cellsInflammation-associated nitrotyrosination affects TCR recognition through reduced stability and alteration of the molecular surface of the MHC complexHuman leukocyte antigen genes and interferon beta preparations influence risk of developing neutralizing anti-drug antibodies in multiple sclerosisNitration of the pollen allergen bet v 1.0101 enhances the presentation of bet v 1-derived peptides by HLA-DR on human dendritic cellsIdentification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapyThe contributions of mass spectrometry to understanding of immune recognition by T lymphocytes.Employing a recombinant HLA-DR3 expression system to dissect major histocompatibility complex II-thyroglobulin peptide dynamism: a genetic, biochemical, and reverse immunological perspective.Monocyte-derived dendritic cells exhibit increased levels of lysosomal proteolysis as compared to other human dendritic cell populations.Towards universal structure-based prediction of class II MHC epitopes for diverse allotypes.Tumor antigen epitopes interpreted by the immune system as self or abnormal-self differentially affect cancer vaccine responses.Reduction of T cell receptor diversity in NOD mice prevents development of type 1 diabetes but not Sjögren's syndrome.Self-pMHCII complexes are variably expressed in the thymus and periphery independent of mRNA expression but dependent on the activation state of the APCsThe melting pot of the MHC II peptidomeTumors reveal their secrets to cytotoxic T cells.Post-translational modification of LipL32 during Leptospira interrogans infectionAutophagy in antigen-presenting cells results in presentation of citrullinated peptides to CD4 T cells.CD8(+) T-cell recognition of a synthetic epitope formed by t-butyl modificationContribution of mass spectrometry-based proteomics to immunology.Identification of T-cell epitopes for cancer immunotherapy.Impact of glycans on T-cell tolerance to glycosylated self-antigens.Up-regulation of NG2 proteoglycan and interferon-induced transmembrane proteins 1 and 3 in mouse astrocytoma: a membrane proteomics approachPeptide-based vaccines for cancer: realizing their potential.Increased diversity of the HLA-B40 ligandome by the presentation of peptides phosphorylated at their main anchor residueEvaluation of cellular immune responses in cancer vaccine recipients: lessons from NY-ESO-1.Revival of the identification of cytotoxic T-lymphocyte epitopes for immunological diagnosis, therapy and vaccine development.Insights into MHC class I antigen processing gained from large-scale analysis of class I ligands.Melanoma vaccines: developments over the past 10 years.Structural basis for self-recognition by autoimmune T-cell receptors.The Human Leukocyte Antigen (HLA)-B27 Peptidome in Vivo, in Spondyloarthritis-susceptible HLA-B27 Transgenic Rats and the Effect of Erap1 Deletion.Interactions of HIV-1 proteins as targets for developing anti-HIV-1 peptides.A Molecular Basis for the Presentation of Phosphorylated Peptides by HLA-B Antigens.Lipopeptides: a novel antigen repertoire presented by major histocompatibility complex class I molecules.Investigation of a new tumor-associated glycosylated antigen as target for dendritic cell vaccination in pancreatic cancer.Mature proteins derived from Epstein-Barr virus fail to feed into the MHC class I antigenic pool.Identification and Characterization of Complex Glycosylated Peptides Presented by the MHC Class II Processing Pathway in Melanoma.Recent insights into CD4+T-cell specificity and function in Type 1 diabetes
P2860
Q27006750-D804A5FE-5C88-477B-AD63-536A562101B3Q27652421-2C4A3DB4-6017-474D-8F82-E9309FA3D270Q27660843-22C10CD0-EA82-4161-B904-92537905EA59Q28481493-70DF3FD4-7DDA-4C73-A258-E4FF35BC5EA3Q28540630-99DD17C0-12B1-4DD9-9B9E-2DECD102E6CDQ28732106-9A5B9CD0-26B7-41E4-B362-4D8C21EE5C62Q30437344-5BD57129-7546-4A45-8320-46B843A6E16EQ30444065-ABF0F972-F368-4A57-ABEE-0E96EC8BF3ECQ33506224-1C2111AA-4A3C-4F1C-82BB-BC70A3575148Q33651251-35FE46ED-A21B-4655-923E-A9E289E609E0Q33781091-1E1DB268-C3C4-4E65-B2F0-2EB6E21D4EA7Q34001211-399361FD-31E7-4409-9593-C319DD793337Q34473302-2E9E8043-90ED-4E8B-A37F-270DAE2C4FD7Q34625501-2A81B7C4-CF9E-4699-9876-BE569DA4E432Q34676583-7EFC838B-AC21-4737-A6EF-2B4D178FE31CQ35075389-E939BBF6-D8C2-435C-80BB-0CBA7F1B7862Q35377257-46A1E507-16DB-4EE5-87C1-EFC2936A3CB7Q35627649-DED6E170-3560-4AA2-B8DA-56023953314AQ36019759-880D4DDB-E6CF-47B5-A864-11F3FE5D0C33Q36689114-690354DA-DE14-405F-8AC4-5147215BD376Q36870592-19B2BEF9-B5EF-4623-8390-CE5C90241593Q37216317-D18B1868-9326-4DC9-860F-BAE13CB7E738Q37303172-E98961BA-EE72-4639-A753-DA5844B5D0EEQ37340462-AABC6783-C4C4-4531-A224-EEE289DC80E2Q37563889-09F2DBB1-122A-49ED-9A4F-B161B4FF9D42Q37762274-EE03B87C-ACAD-48ED-96D0-CBEE6C972156Q37844333-C0BDF72E-46BC-48AF-9D45-6E06B7F671D2Q37851048-075E5862-AE47-4BE2-9BE9-A7B3E56262C0Q37892595-7AEB282E-1031-47A8-817A-CAC3E53BB3A6Q38050478-8B82BFB6-A798-4F8D-BD58-3E61CF8EB860Q38380973-44535AA3-166B-4FFB-B47B-E2EC002AAC10Q38524164-D6BAF349-75A7-41C8-9041-00D579DB927DQ38727506-784BF0DA-E3AE-4053-9378-AD51CD0C0D53Q38893422-F2E2F61C-847C-4C9F-912E-78F2F0F2D33CQ41876001-F1F5D2C5-22D4-476A-9AC6-E842733EC1FFQ45355050-038A66F5-7339-4736-8BFB-7F6F31066788Q51556710-28B06A55-EF3C-49ED-B726-E0EEB6F1895BQ58233277-1F1A2415-2E8A-4094-B4A3-C60B55AAB5D1
P2860
Post-translational modifications of naturally processed MHC-binding epitopes.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Post-translational modifications of naturally processed MHC-binding epitopes.
@ast
Post-translational modifications of naturally processed MHC-binding epitopes.
@en
type
label
Post-translational modifications of naturally processed MHC-binding epitopes.
@ast
Post-translational modifications of naturally processed MHC-binding epitopes.
@en
prefLabel
Post-translational modifications of naturally processed MHC-binding epitopes.
@ast
Post-translational modifications of naturally processed MHC-binding epitopes.
@en
P2093
P1476
Post-translational modifications of naturally processed MHC-binding epitopes.
@en
P2093
Angela L Zarling
Marina Ostankovitch
Michelle Altrich-Vanlith
P356
10.1016/J.COI.2005.11.015
P577
2005-12-15T00:00:00Z